FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190486469> ?p ?o ?g. }

• W3190486469 endingPage "285" @default.
• W3190486469 startingPage "266" @default.
• W3190486469 abstract "Alzheimer's disease (AD) is an intensifying neurodegenerative illness due to its irreversible nature. Identification of β-site Amyloid Precursor Protein (APP) cleaving en-zyme1 (BACE1) has been a significant medicinal focus towards AD treatment, and this has opened ground for several investigations. Despite the numerous works in this direction, no BACE1 inhibitor has made it to the final approval stage as an anti-AD drug.We provide an introductory background of the subject with a general overview of the pathogenesis of AD. The review features BACE1 inhibitor design and development with a focus on some clinical trials and discontinued drugs. Using the topical keywords BACE1, inhibitor design, and computational/theoretical study in the Web of Science and Scopus database, we retrieved over 49 relevant articles. The search years are from 2010 and 2020, with analysis conducted from May 2020 to March 2021.Researchers have employed computational methodologies to unravel po-tential BACE1 inhibitors with a significant outcome. The most used computer-aided approach in BACE1 inhibitor design and binding/interaction studies are pharmacophore development, quantita-tive structure-activity relationship (QSAR), virtual screening, docking, and molecular dynamics (MD) simulations. These methods, plus more advanced ones including quantum mechan-ics/molecular mechanics (QM/MM) and QM, have proven substantial in the computational frame-work for BACE1 inhibitor design. Computational chemists have embraced the incorporation of in vitro assay to provide insight into the inhibition performance of identified molecules with potential inhibition towards BACE1. Significant IC50 values up to 50 nM, better than clinical trial com-pounds, are available in the literature.The continuous failure of potent BACE1 inhibitors at clinical trials is attracting many queries prompting researchers to investigate newer concepts necessary for effective inhibitor de-sign. The considered properties for efficient BACE1 inhibitor design seem enormous and require thorough scrutiny. Lately, researchers noticed that besides appreciable binding affinity and Blood-Brain Barrier (BBB) permeation, BACE1 inhibitor must show low or no affinity for permeability-glycoprotein. Computational modeling methods have profound applications in drug discovery strat-egies. With the volume of recent in silico studies on BACE1 inhibition, the prospect of identifying potent molecules that would reach the approved level is feasible. Investigators should try pushing many of the identified BACE1 compounds with significant anti-AD properties to preclinical and clinical trial stages. We also advise computational research on allosteric inhibitor design, exosite modeling, and multisite inhibition of BACE1. These alternatives might be a solution to BACE1 drug discovery in AD therapy." @default.
• W3190486469 created "2021-08-16" @default.
• W3190486469 creator A5005397606 @default.
• W3190486469 creator A5053975561 @default.
• W3190486469 creator A5055206316 @default.
• W3190486469 creator A5064052752 @default.
• W3190486469 date "2022-02-01" @default.
• W3190486469 modified "2023-10-01" @default.
• W3190486469 title "Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus on Computer-aided Inhibitor Design" @default.
• W3190486469 cites W1495784801 @default.
• W3190486469 cites W1547008896 @default.
• W3190486469 cites W1602771322 @default.
• W3190486469 cites W1605885548 @default.
• W3190486469 cites W1816679421 @default.
• W3190486469 cites W1854324009 @default.
• W3190486469 cites W1894615480 @default.
• W3190486469 cites W1964203690 @default.
• W3190486469 cites W1964822121 @default.
• W3190486469 cites W1964927978 @default.
• W3190486469 cites W1967450294 @default.
• W3190486469 cites W1967590556 @default.
• W3190486469 cites W1968344479 @default.
• W3190486469 cites W1976118830 @default.
• W3190486469 cites W1977282090 @default.
• W3190486469 cites W1977877089 @default.
• W3190486469 cites W1978367874 @default.
• W3190486469 cites W1980119907 @default.
• W3190486469 cites W1982019927 @default.
• W3190486469 cites W1985782250 @default.
• W3190486469 cites W1988281445 @default.
• W3190486469 cites W1989753444 @default.
• W3190486469 cites W1989820287 @default.
• W3190486469 cites W1993426606 @default.
• W3190486469 cites W1999491936 @default.
• W3190486469 cites W2004303971 @default.
• W3190486469 cites W2007787335 @default.
• W3190486469 cites W2008041561 @default.
• W3190486469 cites W2009277432 @default.
• W3190486469 cites W2009970240 @default.
• W3190486469 cites W2010925911 @default.
• W3190486469 cites W2021602387 @default.
• W3190486469 cites W2026422955 @default.
• W3190486469 cites W2027853783 @default.
• W3190486469 cites W2036028081 @default.
• W3190486469 cites W2038003980 @default.
• W3190486469 cites W2042069812 @default.
• W3190486469 cites W2048966170 @default.
• W3190486469 cites W2053717624 @default.
• W3190486469 cites W2053995492 @default.
• W3190486469 cites W2055945817 @default.
• W3190486469 cites W2062094928 @default.
• W3190486469 cites W2063808031 @default.
• W3190486469 cites W2066621849 @default.
• W3190486469 cites W206792683 @default.
• W3190486469 cites W2068113465 @default.
• W3190486469 cites W2068682736 @default.
• W3190486469 cites W2069924395 @default.
• W3190486469 cites W2074142600 @default.
• W3190486469 cites W2076658253 @default.
• W3190486469 cites W2079191076 @default.
• W3190486469 cites W2081618506 @default.
• W3190486469 cites W2083219790 @default.
• W3190486469 cites W2084398285 @default.
• W3190486469 cites W2084698610 @default.
• W3190486469 cites W2085051731 @default.
• W3190486469 cites W2086729582 @default.
• W3190486469 cites W2087581147 @default.
• W3190486469 cites W2090661905 @default.
• W3190486469 cites W2093931325 @default.
• W3190486469 cites W2094353481 @default.
• W3190486469 cites W2096584150 @default.
• W3190486469 cites W2096923984 @default.
• W3190486469 cites W2102174621 @default.
• W3190486469 cites W2103440561 @default.
• W3190486469 cites W2109366922 @default.
• W3190486469 cites W2109550688 @default.
• W3190486469 cites W2109699895 @default.
• W3190486469 cites W2114358369 @default.
• W3190486469 cites W2130479394 @default.
• W3190486469 cites W2133019124 @default.
• W3190486469 cites W2135732933 @default.
• W3190486469 cites W2139018071 @default.
• W3190486469 cites W2141095292 @default.
• W3190486469 cites W2146670116 @default.
• W3190486469 cites W2147858709 @default.
• W3190486469 cites W2154670681 @default.
• W3190486469 cites W2164594351 @default.
• W3190486469 cites W2169356930 @default.
• W3190486469 cites W2196381211 @default.
• W3190486469 cites W2214346462 @default.
• W3190486469 cites W2229673765 @default.
• W3190486469 cites W2255685523 @default.
• W3190486469 cites W2270734273 @default.
• W3190486469 cites W2283677448 @default.
• W3190486469 cites W2285695389 @default.
• W3190486469 cites W2298887234 @default.
• W3190486469 cites W2310421983 @default.
• W3190486469 cites W2317932366 @default.

• next